The US FDA has approved a synthetic tissue substitute for the eye that will address the worldwide shortage of donors. The EverPatch from Israel’s CorNeat Vision (see here previously) is made of a polymer that stimulates the cells to accept … Continue reading →

Israel’s CorNeat KPro synthetic cornea, which was successfully implanted into Jamal Furani in February (see here), is now to be trialed in Israel, Canada, France, the US and the Netherlands. 30 million people are blind in at least one eye, … Continue reading →

Surgeons at Rambam Medical Center conducted the first implant of a synthetic cornea from Israel’s CorNeat (reported here previously). 78-year-old Israeli Arab Jamal from Haifa was able to see clearly immediately after the transplant, for the first time in 10 … Continue reading →

The synthetic cornea from Israel’s CorNeat is beginning human trials, as reported here in July. This has become vital due to shortage of human corneas during Covid-19. CorNeat will soon begin trials of its EverPatch for Glaucoma surgery and is … Continue reading →

Israel has approved the first-in-human synthetic corneal transplants. Surgeons at Israel’s Beilinson Hospital will operate to restore the sight of 10 Israelis using KPro implants from Israel’s CorNeat Vision (reported here previously). If OK, Canada, the US, France, China and … Continue reading →

Israeli startup CorNeat Vision has completed the design and development stage of its artificial cornea implant. The CorNeat KPro is produced using nanoscale chemical engineering that stimulates cellular growth. CorNeat is aiming for its first implantation in humans by mid-2018. … Continue reading →